Peloton has confidentially filed for an initial public offering in the US that would follow $995m of equity funding and provide exits for Comcast and Grace Beauty.

The real estate deals database has secured a mixture of equity and debt financing from Susquehanna Growth Equity, and will redeem series A shares owned by DMGT.

Sales-team support software provider Highspot has now raised a total of $122m, having secured additional funding from investors including Salesforce Ventures.

The cloud-based collaboration network increased its overall funding to $36m with a series B round backed by Microsoft's M12 subsidiary.

Deerfield Management and Columbia University have launched a $130m commercialisation fund, Hudson Heights Innovation, to support the university's early-stage biomedical research.

Johnson Controls-backed energy efficiency services provider Carbon Lighthouse has received $32.6m in a round that included $20m from Cox Enterprises.

Boehringer Ingelheim Venture Fund co-led the oncology drug developer's series A round with Delos Capital and Xeraya Capital.

OncoMyx Therapeutics was co-founded by ASU's Grant McFadden and will use the series A funding to advance the development of its lead asset aimed at several indications of cancer.

UT Health's pulmonary drug treatment spinout Lung Therapeutics has raised a $36m series C, adding to at least $55m in previous funding from backers including UT Horizon Fund.

University of Colorado Hospital-affiliated UC Health and University of Virginia LVG Venture Fund both featured in a series A round for healthcare analytics platform creator RxRevu.